DIA EUROPE 2019

Back to Agenda

How to Facilitate Access to Advanced Therapy Medicinal Products in Europe

Session Chair(s)

Maria Pascual, PharmD

Chair of Advanced Therapies Working Group

EBE-EFPIA, Spain

This session will focus on current experiences and challenges surrounding the market access of advanced therapy medicinal products. (ATMPs). The session will also highlight opportunities to secure access for patients to these innovative therapies, in particular for ATMPs addressing diseases with high unmet medical needs.

Speaker(s)

Can We Improve Access to ATMPs? The Results of ARM’s Multi-Stakeholder Study

Paolo Morgese, MSc

Alliance for Regenerative Medicine (ARM), Belgium

Head of Public Affairs

Practical Challenges for Access of ATMPs in Europe – An Industry Perspective

Etienne Jousseaume

Novartis, Switzerland

Head Market Access Cell and Gene Europe

Challenges in the Development of ATMPs in Europe – A Regulator Perspective

Ilona Reischl, PhD, MPharm

Austrian Medicines and Medical Devices Agency (AGES MEA), Austria

Biologics Quality Assessor

Have an account?